Guerrero Olivos assisted Empresas Masvida S.A. (“EMV”), MV Clinical S.A. (“MVC”), and MV Financial S.A. (“MVF”), a relevant local holding engaged in the health and health administration industry (“the Holding”), in the negotiation and execution of a strategic collaboration agreement with real estate investors Inversiones Valmar Limitada and Madesal S.A. This agreement was materialized through the sale of 51% of the Holding to a joint venture specially structured for this transaction, Valsal SpA.
Relevance to this assistance is that the transaction had to be approved by the National Antitrust Prosecutor, for merger control review purposes. Approval was successfully granted on May 2018. Also, due to the financial situation of EMV, our group had to structure and implement an internal reorganization of the Holding and its related parties, to concentrate the % to be divested in one sole entity. EMV is under an insolvency and restructuring regime ruled under Law 20.720.
Counsel list
Guerrero Olivos as counsel to the Holding: Lead partner: Clemente Pérez (projects and regulatory) cperez@guerrero.cl. Other team members: Senior associates Jaime Barahona (antitrust) jbarahona@guerrero.cl and Tomás Kubick (corporate/M&A and antitrust) tkubick@guerrero.cl. Junior associate Tomás Montes (corporate and M&A) tmontes@guerrero.cl.
Date of closing
15/7/2018
Deal Value
CLP11.745.000.000
